Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cetuximab (erbitux) (1 trial)
fluorouracil (efudex) (1 trial)
irinotecan (Camptosar) (1 trial)
oxaliplatin (eloxatin) (1 trial)
Colorectal Neoplasms (Phase 2)
Liver Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms, Second Primary (Phase 2)
Trials (1 total)
Trial APIs (4 total)